Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Profound Medical (PROF) Non-Current Receivables (2018 - 2024)

Profound Medical has reported Non-Current Receivables over the past 7 years, most recently at $310000.0 for Q3 2024.

  • For Q3 2024, Non-Current Receivables rose 300.0% year-over-year to $310000.0; the TTM value through Sep 2024 reached $310000.0, up 300.0%, while the annual FY2023 figure was $7.3 million, 14.88% up from the prior year.
  • Non-Current Receivables for Q3 2024 was $310000.0 at Profound Medical, down from $484000.0 in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $7.0 billion in Q1 2023 and troughed at -$365000.0 in Q1 2022.
  • A 5-year average of $370.3 million and a median of $1.2 million in 2022 define the central range for Non-Current Receivables.
  • Biggest five-year swings in Non-Current Receivables: tumbled 133.52% in 2022 and later soared 1916538.36% in 2023.
  • Year by year, Non-Current Receivables stood at $5700.0 in 2020, then surged by 63444.05% to $3.6 million in 2021, then surged by 75.15% to $6.3 million in 2022, then grew by 14.88% to $7.3 million in 2023, then crashed by 95.75% to $310000.0 in 2024.
  • Business Quant data shows Non-Current Receivables for PROF at $310000.0 in Q3 2024, $484000.0 in Q2 2024, and $1.3 million in Q1 2024.